Clinical Trials › NCT04956744
RecruitingPhase 1
A Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of IMS001 in Subjects With Multiple Sclerosis
Sponsored by ImStem Biotechnology
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 30
Target enrollment
3
U.S. states
Aug 2021
Start date
Dec 2027
Expected completion
Interventions / Treatments
IMS001
Conditions studied
Multiple Sclerosis
Where this trial is running (3 sites)
Participating MS centers on MS Buddy (3)
Rocky Mountain Multiple Sclerosis Clinic
Salt Lake City, UT
Salt Lake City, UT
UMass Memorial Medical Center MS Clinic
Worcester, MA
Worcester, MA
Andrew C. Carlos MS Institute at Shepherd
Atlanta, GA
Atlanta, GA
MS centers in Georgia
Compare treatment centers near a trial site — patient experience, providers, and care ratings.
View Georgia centersMore Phase 1 trials
Browse all Phase 1 MS trialsCheck out the MS Buddy App
Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
